Henry I. Miller


Henry I. Miller, MS, MD, was the Robert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover Institution. His research focused on public policy toward science and technology, encompassing a number of areas, including pharmaceutical development, genetic engineering in agriculture, models for regulatory reform, and the emergence of new viral diseases.

Miller served for fifteen years at the US Food and Drug Administration (FDA) in a number of posts. He was the medical reviewer for the first genetically engineered drugs to be evaluated by the FDA and thus instrumental in the rapid licensing of human insulin and human growth hormone. Thereafter, he was a special assistant to the FDA commissioner and the founding director of the FDA's Office of Biotechnology. During his government service, Miller participated frequently on various expert and policy panels as a representative of the FDA or the US government. As a government official, Miller received numerous awards and citations.

During his time at the Hoover Institution, Miller has become well known not only for his contributions to scholarly journals but also for his articles and books that make science, medicine, and technology accessible. His work has been widely published in many languages. Monographs include Policy Controversy in Biotechnology: An Insider's View; To America's Health: A Model for Reform of the Food and Drug Administration; and The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution. Barron's selected The Frankenfood Myth as one of the 25 Best Books of 2004. In addition, Miller has published extensively in a wide spectrum of scholarly journals and popular publications worldwide, including The Lancet, Journal of the American Medical Association, Science, the Nature family of journals, Chronicle of Higher Education, Forbes, National Review, Wall Street Journal, New York Times, the Guardian, Defining Ideas, and the Financial Times. He was a regulator contributor to Forbes.com and frequently appeared on the nationally syndicated radio programs of John Batchelor and Lars Larson.

Miller was selected by the editors of Nature Biotechnology as one of the people who had made the "most significant contributions" to biotechnology during the previous decade. He serves on numerous editorial boards.

Filter By:



Recent Commentary

Be Afraid

by Henry I. Millervia Hoover Digest
Sunday, October 30, 2005

The avian flu is already responsible for more than 60 human deaths. If it mutates into a virus transmissible between humans—a real possibility—we could see a worldwide pandemic. How to fight the flu. By Henry I. Miller.

Why We Lacked Resilience

by Henry I. Millervia Hoover Digest
Saturday, July 30, 2005

How could one storm score a hit on every wallet in the country? By Henry I. Miller.

The U.N., Biotechnology, and the Poorest of the Poor

by Henry I. Miller, Gregory Conkovia Hoover Digest
Saturday, April 30, 2005

How the U.N.’s systematic sacrifice of science, technology, and sound public policy to its own bureaucratic self-interest obstructs technological innovation and hurts the poorest of the poor. By Henry I. Miller and Gregory Conko.

Analysis and Commentary

Tough Times at the FDA

by Henry I. Millervia Hoover Daily Report
Wednesday, April 27, 2005

The "safety" of a drug is a relative thing.

this is an image

Pathological Science

by Henry I. Millervia Hoover Digest
Sunday, January 30, 2005

Health scares based on bad data represent a growing problem. By Henry I. Miller.

Politics vs. Science

by Elizabeth M. Whelan, Henry I. Millervia Hoover Digest
Saturday, October 30, 2004

The case for federal funding of stem-cell research. By Elizabeth M. Whelan and Henry I. Miller.

How Not to Make Science Policy

by Henry I. Millervia Hoover Digest
Friday, July 30, 2004

Why science and popular opinion don’t always mix. By Henry I. Miller.

Technology’s Unworthy Adversaries

by Gregory Conko, Henry I. Millervia Hoover Digest
Friday, April 30, 2004

The enormous benefits of genetically engineered agriculture have been proven. What have not been proven are the spurious claims of its critics. By Hoover fellow Henry I. Miller and Gregory Conko.

Analysis and Commentary

A Better Environment for Endangered Species

by Henry I. Millervia Hoover Daily Report
Monday, February 16, 2004

Environmental groups have filed a spate of nuisance lawsuits that attempt to prevent the Environmental Protection Agency (EPA) from registering or reregistering pesticides.

Can Dr. McClellan Cure the FDA?

by Henry I. Millervia Hoover Digest
Friday, January 30, 2004

Americans are dying for regulatory reform—literally. By Hoover fellow Henry I. Miller.